Understanding the Use of Voluntary Notification (VNS) for Health Supplements in Singapore

---

Key Considerations

• Health supplements in Singapore are not subject to pre-market approval.
• The Voluntary Notification System (VNS) allows companies to submit product information on a voluntary basis.
• VNS does not constitute regulatory approval or endorsement.
• Companies remain fully responsible for ensuring compliance prior to market entry.
• In practice, VNS may be used as part of internal documentation or where requested by major pharmacy stores.

Health supplements in Singapore are not subject to pre-market approval. However, the Health Sciences Authority provides a Voluntary Notification System (VNS), which allows companies to submit product information on a voluntary basis.

While VNS is not a regulatory requirement, it may be used in practice as part of a company’s internal regulatory documentation or where requested by distributors and retailers prior to product onboarding.

1. Role of VNS in Supporting Regulatory Documentation

In practice, distributors and retailers may require evidence of regulatory assessment or supporting product documentation prior to onboarding.

While not mandated by the authority, participation in VNS may be used by companies as part of their documentation to facilitate such discussions.

2. Use of VNS in Market Access and Distribution

Participation in the Voluntary Notification System (VNS) may be considered as part of a company’s internal regulatory documentation approach.

In practice, distributors and retailers may request supporting product information prior to onboarding. This typically includes product composition, labelling and relevant compliance documentation.

Where applicable, VNS may be used as part of the overall documentation set to support such discussions. However, it should be noted that VNS itself does not replace the need for proper regulatory assessment prior to market entry.

3. Limitations of VNS from a Regulatory Perspective

While VNS allows companies to submit product information on a voluntary basis, it does not constitute regulatory approval or endorsement by the Health Sciences Authority.

Participation in VNS does not exempt companies from ensuring that their products comply with all applicable safety, quality and labelling requirements prior to market entry.

As such, reliance on VNS alone without a structured regulatory assessment may lead to gaps in compliance.

4. Avoiding Misinterpretation of VNS

A common misconception is that participation in VNS equates to regulatory clearance or facilitates automatic market access.

In practice, companies remain fully responsible for ensuring that their products meet prevailing regulatory requirements at the point of importation and sale.

Maintaining proper documentation and conducting a structured regulatory assessment upfront are key to avoiding potential compliance issues post-market.

5. Role of VNS in Overall Regulatory Approach

While VNS may be used as part of a company’s documentation process, it should be considered within the context of a broader regulatory strategy.

It is not a substitute for classification assessment, ingredient review, or evaluation of product claims.

A structured regulatory approach remains necessary to ensure that products are appropriately positioned and compliant with local requirements prior to market entry.

Practical Considerations Prior to Participation in VNS

Companies considering participation in VNS should ensure that:

• product classification has been appropriately determined
• supporting documentation (e.g. formulation, test reports, labelling) is available
• local representation is established where required

In practice, this is often undertaken as part of a broader regulatory assessment prior to market entry.

Secure Long-Term Success in the Wellness Sector

While VNS may be considered as part of a company’s regulatory approach, it should not be viewed as a substitute for a structured regulatory assessment.

TRC supports clients on an end-to-end basis, from initial regulatory evaluation through to market entry planning and compliance alignment, particularly for companies entering Singapore without an established local regulatory function.

Take the first step now. Contact us today.

• Share This Article:

---